TRANYLCYPROMINE SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Tranylcypromine Sulfate patents expire, and what generic alternatives are available?
Tranylcypromine Sulfate is a drug marketed by Crossmedika Sa, Novitium Pharma, and Strides Pharma. and is included in three NDAs.
The generic ingredient in TRANYLCYPROMINE SULFATE is tranylcypromine sulfate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the tranylcypromine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tranylcypromine Sulfate
A generic version of TRANYLCYPROMINE SULFATE was approved as tranylcypromine sulfate by STRIDES PHARMA on June 29th, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRANYLCYPROMINE SULFATE?
- What are the global sales for TRANYLCYPROMINE SULFATE?
- What is Average Wholesale Price for TRANYLCYPROMINE SULFATE?
Summary for TRANYLCYPROMINE SULFATE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Patent Applications: | 1 |
| What excipients (inactive ingredients) are in TRANYLCYPROMINE SULFATE? | TRANYLCYPROMINE SULFATE excipients list |
| DailyMed Link: | TRANYLCYPROMINE SULFATE at DailyMed |
Pharmacology for TRANYLCYPROMINE SULFATE
| Drug Class | Monoamine Oxidase Inhibitor |
| Mechanism of Action | Monoamine Oxidase Inhibitors |
Medical Subject Heading (MeSH) Categories for TRANYLCYPROMINE SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for TRANYLCYPROMINE SULFATE
US Patents and Regulatory Information for TRANYLCYPROMINE SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Crossmedika Sa | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | TABLET;ORAL | 213503-001 | Jun 27, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Novitium Pharma | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | TABLET;ORAL | 206856-001 | Apr 17, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Strides Pharma | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | TABLET;ORAL | 040640-001 | Jun 29, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
